<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2019</YEAR>
<VOL>23</VOL>
<NO>1</NO>
<MOSALSAL>72</MOSALSAL>
<PAGE_NO>69</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Effect of allopurinol and benzbromarone on diabetic cardiomyopathy and vasculopathy in streptozotocin-induced diabetic rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Allopurinol, a xanthine oxidase inhibitor, reduces both plasma uric acid (UA) and oxidative stress, and benzbromarone, a uricosuric agent, reduces the level of plasma UA. This study was designed to evaluate cardiac mechanical and endothelial functions of the allopurinol- and benzbromarone-treated diabetic rats, and to investigate the underlying mechanism (antioxidant or UA lowering activity) of allopurinol beneficial effects. Methods: Diabetes was induced by injecting streptozotocin to male Spargue-Dawley rats. Diabetic animals were treated with allopurinol and benzbromarone. After six weeks of treatment, left ventricular systolic/diastolic functions of hearts, contraction/relaxation responses to phenylephrine and acetylcholine of aortae, and serum levels of malondialdehyde, 8-isoprostane-2&#945; and UA were measured. Results: Diabetic cardiomyopathy and vasculopathy were characterized by reduced myocardial performance and decreased aortic endothelial response to the vasorelaxation effect of acetylcholine. The serum levels of malondialdehyde and 8-isoprostane-2&#945; levels were elevated in diabetic animals. Allopurinol attenuated the diabetes-induced diastolic impairment of the hearts, endothelial dysfunction of the aortae and decreased oxidative stress parameters in serum; however, benzbromarone had none of these effects. Both, allopurinol and benzbromarone, diminished the elevated levels of UA in diabetic animals. Conclusion: Allopurinol improved diabetic cardiomyopathy and aortic endothelial cell dysfunction in diabetic animals through antioxidant effects.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>1</FPAGE>
			<TPAGE>8</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/9
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/5/18
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/21
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/11/1
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mohammad</Name>
				<MidName></MidName>
				<Family>Fathalipour</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fathalipour</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Fathalipour@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hossein</Name>
				<MidName></MidName>
				<Family>Mirkhani</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mirkhani</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mirkhanh@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohsen</Name>
				<MidName></MidName>
				<Family>Goharinia</Family>
				<NameE>Mohsen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Goharinia</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>M.goharinia@fums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Allopurinol</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Benzbromarone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cardiomyopathy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Endothelial dysfunction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Diabetes.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Afshari M, Larijani B, Rezaie A, Mojtahedi A, Zamani MJ, Astanehi-Asghari F, et al. In effectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 2004; 58: 546-50.##Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J 2016; 24: 547-553.##Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 2010; 11: 31-9.##Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.##Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-51.##Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, et al. Defective intracellular Ca2+ signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283: H1398-408.##Desco MC, Asensi M, Márquez R, Martínez-Valls J, Vento M, Pallardó FV, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002; 51: 1118-24.##Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123-32.##George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114: 2508-16.##Goharinia M, Zareei A, Rahimi M, Mirkhani H. Can allopurinol improve retinopathy in diabetic rats? Oxidative stress or uric acid; which one is the culprit?. Res Pharm Sci 2017; 12: 401-408.##Gokce G, Haznedaroglu MZ. Evaluation of antidiabetic, antioxidant and vasoprotective effects of Posidonia oceanica extract. J Ethnopharmacol 2008; 115: 122-30.##Haznedaroglu MZ, Gokce G. Zostera noltii extract lowers blood glucose and restores vascular function in diabetic rats. Bangladesh J Pharmacol 2014; 9: 389-97.##Hwang SJ, Lee KH, Jang HH, Lee SR, Woo JS, Lee HJ, et al. Febuxostat contributes to improvement of endothelial dysfunction in an experimental model of streptozocin-induced diabetic rats. Int J Cardiol 2014; 171: e110-2.##Inkster ME, Cotter MA, Cameron NE. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur J Pharmacol 2007; 561: 63-71.##Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, et al. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Mol Cell Biochem 2014; 386: 233-49.##Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M, et al. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol 2014; 39: 348-56.##Kaufmann P, Török M, Hänni A, Roberts P, Gasser R, Krähenbühl S. Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity. Hepatology 2005; 41: 925-35.##Kobayashi S, Liang Q. Autophagy and mitophagy in diabetic cardiomyopathy. Biochim Biophys Acta 2015; 1852: 252-61.##Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, et al. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol 2009; 297: F481-8.##Lau LW, Cua R, Keough MB, Haylock-Jacobs S, Yong VW. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci 2013; 14: 722-9.##Muraya N, Kadowaki D, Miyamura S, Kitamura K, Uchimura K, Narita Y, et al. Benzbromarone attenuates oxidative stress in angiotensin II-and salt-induced hypertensive model rats. Oxid Med Cell Longev 2018; 2018 :7635274.##op den Buijs J, Miklós Z, van Riel NA, Prestia CM, Szenczi O, Tóth A, et al. β-adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes. Life Sci 2005; 76: 1083-98.##Rajesh M, Mukhopadhyay P, Bátkai S, Mukhopadhyay B, Patel V, Haskó G, et al. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 2009; 13: 2330-41.##Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta 2014; 1840: 2709-29.##Roghani M, Vaez Mahdavi MR, Jalali‐Nadoushan MR, Baluchnejadmojarad T, Naderi G, Roghani‐Dehkordi F, et al. Chronic administration of daidzein, a soybean isoflavone, improves endothelial dysfunction and attenuates oxidative stress in streptozotocin‐induced diabetic rats. Phytother Res 2013; 27: 112-7.##Sena CM, Pereira AM, Seiça R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta 2013; 1832: 2216-31.##Sheikh AQ, Hurley JR, Huang W, Taghian T, Kogan A, Cho H, et al. Diabetes alters intracellular calcium transients in cardiac endothelial cells. PloS one 2012; 7: e36840.##Sun P, Zhu JJ, Wang T, Huang Q, Zhou YR, Yu BW, et al. Benzbromarone aggravates hepatic steatosis in obese individuals. Biochim Biophys Acta Mol Basis Dis 2018; 1864: 2067-77.##Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 537-46.##Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord 2010; 11: 61-74.##Talebianpoor MS, Mirkhani H. The effect of tempol administration on the aortic contractile responses in rat preeclampsia model. ISRN pharmacol 2012; 2012: 187208.##Zhu J, Wang CG, Xu YG. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress. Pharm Biol 2011; 49: 1144-9.##Zoppini G, Targher G, Bonora E. The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review. J Endocrinol Invest 2011; 34: 881-6.##Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M, et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009; 32: 1716-20.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Antidiabetic effect of hydroethanolic extract of Crocus sativus stigmas, tepals and leaves in streptozotocin-induced diabetic rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: The present study investigated for the first time, the antihyperglycemic effect of tepals and leaves of Crocus sativus in streptozotocin-induced diabetic rats. The effect of these by-products were compared with that of saffron stigma and glibenclamide. Methods: Hydroethanolic extracts (stigmas, tepals and leaves) and glibenclamide were administered orally in aqueous solution daily for 21 days. In the present study, 36 male rats were used. Six rats were used in each group. Group 1: normal control rats (N), received distilled water; group 2: diabetic control rats (D), received distilled water; group 3: treated diabetic rats (TPL), received tepal (TPL) extract; group 4: treated diabetic rats (STG), received stigma (STG) extract; group 5: treated diabetic rats (LF), received leaf (LF) extract and group 6: treated diabetic rats (GLB), received glibenclamide (GLB). Blood glucose, body weight, water intake, urine elimination, plasma triglycerides, cholesterol, urea, creatinine, aspartate amino transferase (AST) and alanine amino transferase (ALT) levels were evaluated. Results: The present data indicated that the tepals and stigmas extracts significantly prevented decreasing body weight and protected against elevation of water intake, urine elimination, blood glucose, plasma triglycerides, cholesterol, urea, creatinine, AST and ALT levels in treated diabetic rats as compared to untreated diabetic rats. Leaves extract significantly prevented decreasing body weight. It decreased water intake, blood glucose, plasma triglycerides, cholesterol, creatinine, AST and ALT. Conclusion: Based on our data, the oral administration of tepals, stigmas and leaves extract of Crocus sativus reduces blood glucose levels and improves control of diabetes complications.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>9</FPAGE>
			<TPAGE>20</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/11
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/7/19
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/15
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/11/26
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Sabir</Name>
				<MidName></MidName>
				<Family>Ouahhoud</Family>
				<NameE>Sabir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ouahhoud</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>s.ouahhoud@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Iliass</Name>
				<MidName></MidName>
				<Family>Lahmass</Family>
				<NameE>Iliass</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Lahmass</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>i.lahmass@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohamed</Name>
				<MidName></MidName>
				<Family>Bouhrim</Family>
				<NameE>Mohamed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bouhrim</FamilyE>
				<Organizations>
				<Organization>Laboratory of Physiology, Genetic and Ethnopharmacology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>m.bouhrim@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Amine</Name>
				<MidName></MidName>
				<Family>Khoulati</Family>
				<NameE>Amine</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khoulati</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>a.khoulati@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Assia</Name>
				<MidName></MidName>
				<Family>Sabouni</Family>
				<NameE>Assia</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sabouni</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>a.sabouni@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Redouanae</Name>
				<MidName></MidName>
				<Family>Benabbes</Family>
				<NameE>Redouanae</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Benabbes</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>r.benabbes@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Abdeslam</Name>
				<MidName></MidName>
				<Family>Asehraou</Family>
				<NameE>Abdeslam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asehraou</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>a.asehraou@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammed</Name>
				<MidName></MidName>
				<Family>Choukri</Family>
				<NameE>Mohammed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Choukri</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry, Central Laboratory Service - CHU, Mohammed VI, Faculty of Medicine and Pharmacy, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>m.choukri@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohamed</Name>
				<MidName></MidName>
				<Family>Bnouham</Family>
				<NameE>Mohamed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bnouham</FamilyE>
				<Organizations>
				<Organization>Laboratory of Physiology, Genetic and Ethnopharmacology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>m.bnouham@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ennouamane</Name>
				<MidName></MidName>
				<Family>Saalaoui</Family>
				<NameE>Ennouamane</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Saalaoui</FamilyE>
				<Organizations>
				<Organization>Laboratory of Biochemistry and Biotechnology, Department of Biology, Faculty of Sciences, University Mohamed Premier, Oujda, Morocco</Organization>
				</Organizations>
				<Countries>
				<Country>Morocco</Country>
				</Countries>
				<EMAILS>
				<Email>e.saalaoui@ump.ac.ma</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Crocus sativus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Antihyperglycemic effect</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Streptozotocine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Saffron</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>By-products.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Akande IS, Ebuehi OA, Samuel TA, Onubogu IC, Esin H. Effects of herbal remedies (Agyanom mixture, Bolex bitters and Remedia mixture) on hepatic and renal functions in male rats. Nig Q J Hosp Med 2010; 20:70-6.##Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Verdi AA, et al. Induction of diabetes by Streptozotocin in rats. Indian J Clin Biochem 2007; 22: 60-4.##Al-Numair KS, Chandramohan G, Veeramani C, Alsaif MA. Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. Redox Rep 2015; 20: 198-209.##Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.##Almdal TP, Petersen KF, Hansen BA, Vilstrup H. Increased capacity of urea synthesis in streptozotocin diabetes in rats. Diabetologia 1986; 29: 812-6.##Altinoz E, Oner Z, Elbe H, Turkoz Y, Cigremis Y. Protective effect of saffron (its active constituent, crocin) on oxidative stress and hepatic injury in streptozotocin induced diabetic rats. Gene Ther Mol Biol 2014; 16: 160-71.##Arasteh A, Aliyev A, Khamnei S, Delazar A, Mesgari Abbasi M, Mehmannavaz Y. Effects of hydromethanolic extract of saffron (Crocus sativus) on serum glucose, insulin and cholesterol levels in healthy male rats. J Med Plants Res 2010; 4: 397-402.##Asri-Rezaei S, Tamaddonfard E, Ghasemsoltani-Momtaz B, Erfanparast A, Gholamalipour S. Effects of crocin and zinc chloride on blood levels of zinc and metabolic and oxidative parameters in streptozotocin-induced diabetic rats. Avicenna J Phytomed 2015; 5: 403-12.##Aybar MJ, Sánchez Riera AN, Grau A, Sánchez SS. Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats. J Ethnopharmacol 2001; 74: 125-32.##Babu PS, Stanely Mainzen Prince P. Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats. J Pharm Pharmacol 2004; 56: 1435-42.##Baer-Dubowska W, Szaefer H, Krajka-Kuzniak V. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds. Xenobiotica 1998; 28: 735-43.##Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013; 12: 43.##Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.##Caballero-Ortega H, Pereda-Miranda R, Abdullaev FI. HPLC quantification of major active components from 11 different saffron (Crocus sativus L.) sources. Food Chem 2007; 100: 1126-31.##Chatterjea MN, Shinde R. Textbook of medical biochemistry: Wife Goes On, 2011.##El-Demerdash FM, Yousef MI, Elagamy EI. Influence of paraquat, glyphosate, and cadmium on the activity of some serum enzymes and protein electrophoretic behavior (in vitro). J Environ Sci Health B 2001; 36: 29-42.##Elgazar AF, Rezq AA, Bukhari HM. Anti-hyperglycemic effect of saffron extract in alloxan-induced diabetic rats. Eur J Biol Sci 2013; 5: 14-22.##Farahmand SK, Samini F, Samini M, Samarghandian S. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver. Biogerontology 2013; 14: 63-71.##Fatehi M, Rashidabady T, Fatehi-Hassanabad Z. Effects of Crocus sativus petals' extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. J Ethnopharmacol 2003; 84: 199-203.##Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57: 1446-54.##Ghadami MR, Pourmotabbed A. The effect of Crocin on scopolamine induced spatial learning and memory deficits in rats. Physiol Pharmacol 2009; 12: 287-95.##Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in CCl 4-induced liver toxicity in mice. Indian J Exp Biol 2009; 47: 257-263.##Goldberg RB. Lipid disorders in diabetes. Diabetes Care 1981; 4: 561-72.##Goupy P, Vian MA, Chemat F, Caris-Veyrat C. Identification and quantification of flavonols, anthocyanins and lutein diesters in tepals of Crocus sativus by ultra performance liquid chromatography coupled to diode array and ion trap mass spectrometry detections. Ind Crops Prod 2013; 44: 496-510.##Hajiaghaalipour F, Khalilpourfarshbafi M, Arya A. Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. Int J Biol Sci 2015; 11: 508-24.##Hakim ZS, Patel BK, Goyal RK. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats. Indian J Physiol Pharmacol 1997; 41: 353-60.##Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010; 11: 1365-402.##Henry RJ. Clinical chemistry; principles and technics. New York: Hoeber Medical Division, 1968.##Hoshyar R, Hosseinian M, Naghandar MR, Hemmati M, Zarban A, Amini Z, et al. Anti-dyslipidemic properties of saffron: reduction in the associated risks of atherosclerosis and insulin resistance. Iran Red Crescent Med J 2016; 18: e36226.##Hossein Goli SA, Mokhtari F, Rahimmalek M. Phenolic compounds and antioxidant activity from saffron (Crocus sativus L.) petal. J Agr Sci 2012; 4: 175-181.##Hosseinzadeh H, Ghenaati J. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia 2006; 77: 446-8.##Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2002; 2: 7.##Kamalakkanan N, Rajadurai M, Prince PS. Effect of Aegle marmelos fruits on normal and streptozotocin-diabetic Wistar rats. J Med Food 2003; 6: 93-8.##Karmen A, Wroblewski F, Ladue JS. Transaminase activity in human blood. J Clin Invest 1955; 34: 126-31.##Kianbakht S, Hajiaghaee R. Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats. J Med Plant 2011; 3: 82-9.##Kubo I, Kinst-Hori I. Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. J Agric Food Chem 1999; 47: 4121-5.##Kumar S, Kumar V, Prakash O. Antidiabetic, hypolipidemic and histopathological analysis of Dillenia indica (L.) leaves extract on alloxan induced diabetic rats. Asian Pac J Trop Med 2011; 4: 347-52.##Lahmass I, Lamkami T, Delporte C, Sikdar S, Van Antwerpen P, Saalaoui E, et al. The waste of saffron crop, a cheap source of bioactive compounds. J Funct Foods 2017a; 35: 341-51.##Lahmass I, Ouahhoud S, Elmansuri M, Sabouni A, Elyoubi M, Benabbas R, et al. Determination of antioxidant properties of six by-products of Crocus sativus L.(saffron) plant products. Waste Biomass Valorization 2018; 9: 1349-57.##Lahmass I, Ouahhoud S, Sabouni A, Elyoubi M, Benabbas R, Elmoussaoui R, et al. Antihyperlipidemic effect of crude extract of saffron (Crocus sativus) stigma in healthy male rats. J Med Allied Sci 2017b; 7: 20-25.##Lahmass I, Sabouni A, Mohammed E, Benabbes R, Mokhtari S, Saalaoui E. Anti-diabetic effect of aqueous extract Crocus sativus L. in tartrazine induced diabetic male rats. Physiol Pharmacol 2017c; 21: 312-21.##Li CY, Lee EJ, Wu TS. Antityrosinase principles and constituents of the petals of Crocus sativus. J Nat Prod 2004; 67: 437-40.##Liu J, Jia L, Kan J, Jin CH. In vitro and in vivo antioxidant activity of ethanolic extract of white button mushroom (Agaricus bisporus). Food Chem Toxicol 2013; 51: 310-6.##Lopresti A, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol 2014; 29: 517-27.##Sabu MC, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 2002; 83: 109-16.##Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol 2004; 92: 85-91.##Maritim AC, Sanders RA, Watkins JB 3rd. Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003; 14: 288-94.##Merzouk H, Madani S, Chabane Sari D, Prost J, Bouchenak M, Belleville J. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes. Clin Sci (Lond) 2000; 98: 21-30.##Mohajeri D, Tabrizi B, Mousavi G, Mesgari Abbasi M. Anti-diabetic activity of Crocus sativus L.(Saffron) stigma ethanolic extract in alloxan-induced diabetic rats. Res J Biol Sci 2008; 3: 1102-1108.##Mohammad R, Daryoush M, Ali R, Yousef D, Mehrdad N. Attenuation of oxidative stress of hepatic tissue by ethanolic extract of saffron (dried stigmas of Crocus sativus L.) in streptozotocin (STZ)-induced diabetic rats. Afr J Pharm Pharmaco 2011; 5: 2166-73.##Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 2006; 13: 607-11.##Mounira L, Bernardo M, Luigi CP, Guido F, Fatima G, Khadija B, Abdelmjid Z, Luisa P. Phytochemical composition of Moroccan saffron accessions by headspace solid-phase-microextraction. Am J Essent Oils Nat Prod 2015; 2: 1-7.##Ong KW, Hsu A, Song L, Huang D, Tan BK. Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. J Ethnopharmacol 2011; 133: 598-607.##Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, Margarity M. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res 2011; 219: 197-204.##Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S. Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2011; 1: 316-22.##Prakash D, Singh BN, Upadhyay G. Antioxidant and free radical scavenging activities of phenols from onion (Allium cepa). Food Chem 2007; 102: 1389-93.##Rajaei Z, Hadjzadeh MA, Nemati H, Hosseini M, Ahmadi M, Shafiee S. Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats. J Med Food 2013; 16: 206-10.##Rajagopal K, Sasikala K. Antihyperglycaemic and antihyperlipidaemic effects of Nymphaea stellata in alloxan-induced diabetic rats. Singapore Med J 2008; 49: 137-41.##Samarghandian S, Azimi-Nezhad M, Farkhondeh T. Immunomodulatory and antioxidant effects of saffron aqueous extract (Crocus sativus L.) on streptozotocin-induced diabetes in rats. Indian Heart J 2017; 69: 151-159.##Samarghandian S, Azimi-Nezhad M, Samini F. Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. Biomed Res Int 2014; 2014: 920857.##Samarghandian S, Borji A. Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients. Pharmacognosy Res 2014; 6: 99-107.##Samarghandian S, Borji A, Delkhosh MB, Samini F. Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J Pharm Pharm Sci 2013; 16: 352-62.##Sánchez-Vioque R, Rodríguez-Conde MF, Reina-Ureña JV, Escolano-Tercero MA, Herraiz-Peñalver D, Santana-Méridas O. In vitro antioxidant and metal chelating properties of corm, tepal and leaf from saffron (Crocus sativus L.). Ind Crops Prod 2012; 39: 149-53.##Sánchez-Vioque R, Santana-Méridas O, Polissiou M, Vioque J, Astraka K, Alaiz M, et al. Polyphenol composition and in vitro antiproliferative effect of corm, tepal and leaf from Crocus sativus L. on human colon adenocarcinoma cells (Caco-2). J Funct Foods 2016; 24: 18-25.##Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 2007; 157: 315-9.##Segal P, Feig PU, Schernthaner G, Ratzmann KP, Rybka J, Petzinna D, et al. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone. Diabetes Care 1997; 20: 687-91.##Serrano-Díaz J, Sánchez AM, Martínez-Tomé M, Winterhalter P, Alonso GL. A contribution to nutritional studies on Crocus sativus flowers and their value as food. J Food Compos Anal 2013; 31: 101-8.##Sheng L, Qian Z, Zheng S, Xi L. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. Eur J Pharmacol 2006; 543: 116-22.##Shirali S, Bathaei SZ, Nakhjavani M, Ashoori MR. Effects of saffron (Crocus sativus L.) aqueous extract on serum biochemical factors in streptozotocin-induced diabetic rats. Iran J Med Aromat Plants 2012; 28: 293-3-8.##Shirali S, Zahra Bathaie S, Nakhjavani M. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res 2013; 27: 1042-7.##Shivanna N, Naika M, Khanum F, Kaul VK. Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana. J Diabetes Complications 2013; 27: 103-13.##Smolskaite L, Talou T, Fabre N, Venskutonis PR. Valorization of saffron industry by-products: bioactive compounds from leaves. InBaltic Conference on Food Science and Technology FoodBalt-2011 2011; 6: 67-72.##Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2006; 290: E1339-46.##Talke H, Schubert GE. Enzymatic urea determination in the blood and serum in the warburg optical test. Klin Wochenschr 1965; 43: 174-5.##Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol 2012; 10: 19-32.##Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-7.##Tuberoso CI, Rosa A, Montoro P, Fenu MA, Pizza C. Antioxidant activity, cytotoxic activity and metabolic profiling of juices obtained from saffron (Crocus sativus L.) floral by-products. Food Chem 2016; 199: 18-27.##Vinayagam R, Xu B. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond) 2015; 12: 60.##Zeka K, Ruparelia KC, Continenza MA, Stagos D, Veglio F, Arroo RRJ. Petals of Crocus sativus L. as a potential source of the antioxidants crocin and kaempferol. Fitoterapia 2015; 107: 128-134.##Zhang Y, Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol 2011; 670: 325-32.##Zheng CJ, Li L, Ma WH, Han T, Qin LP. Chemical constituents and bioactivities of the liposoluble fraction from different medicinal parts of Crocus sativus. Pharm Biol 2011; 49: 756-63.##Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 2016; 12: 616-22.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Ursolic acid increases SIRT1 protein level and β-cells number in diabetic rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Ursolic acid (UA) is a triterpenoid compound which widely found in the apple&#8217;s peel. It has wide health-promoting properties; as previous studies properly indicated to its abilities. In this scenario our attention has been paid to the application of UA as an anti-diabetic compound. Based on our recent studies in relating to SIRT1 protein/gene and UA, the aim of this research was to evaluate UA effects on the SIRT1 expression in diabetic rat&#8217;s pancreas. Methods: In this study we used 20 male diabetic wistar rats. To develop diabetic rats, they received 30mg/kg of streptozotocin for 2 days sequentially. Then, they classified to 2 groups, the ones received UA + corn oil twice daily for two weeks and others (the control group) just received corn oil. Results: Our findings obviously showed that UA enhanced SIRT1 (4&#177;0.2 folds) proteins levels in pancreas (P&#60;0.001), in comparison with control rats. In addition, the findings showed that UA significantly decreased fasting blood glucose from 416.17&#177;12 mg/dl to 149.75&#177;11 mg/dl. Moreover, we found that UA increased &#946;-cell numbers and islet Langerhans diameters (~2 folds). Conclusion: Our results provide valuable information not only into the mechanisms underlying &#946;-cells protection but also into the regulation of SIRT1 as a main target to attenuate &#946;-cells damage. Therefore, UA is a promising pharmacological therapeutic target for &#946;-cell regeneration through enhancing of SIRT1 over-expression.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>21</FPAGE>
			<TPAGE>27</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/21
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/11/1
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/12/9
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Rozita</Name>
				<MidName></MidName>
				<Family>Naseri</Family>
				<NameE>Rozita</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Naseri</FamilyE>
				<Organizations>
				<Organization>Department of Endocrinology and Metabolism, Kermanshah University of Medical Sciences, Kermanshah, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Rozita.Naseri@kums.c.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Bakhtiari</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bakhtiari</FamilyE>
				<Organizations>
				<Organization>Department of Internal- Medicine, Faculty of Medical-sciences, Medical University of Kermanshah, Kermanshah, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>fateme.bakhtiari@kums.c.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Cyrus</Name>
				<MidName></MidName>
				<Family>Jalili</Family>
				<NameE>Cyrus</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jalili</FamilyE>
				<Organizations>
				<Organization>Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>cjalili@kums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nuredin</Name>
				<MidName></MidName>
				<Family>Bakhtiari</Family>
				<NameE>Nuredin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bakhtiari</FamilyE>
				<Organizations>
				<Organization>Department of Biochemistry, Faculty of Biological Sciences, North-Tehran Branches, Islamic Azad university, Tehran, Iran Introduction Diabetes is classified into two main categories based on the clinical presentation and pathophysiology. Type 1 diabetes is characterized by autoimmune β cell destruction. Conversely, type 2 diabetes is caused by a relative insulin deficiency in the face of insulin resistance. Interestingly, recent evidence suggests that silent mating type information regulation 2 homolog1 (SIRT1) modulates immune homeostasis and protection against autoimmunity through inducing of forkhead box P3 (FOXP3) and thereby influences Treg cell development (van Loosdregt et al., 2011). SIRT1 functions as class III histone deacetylases, binding to NAD+ and Physiology Physiology Physiology Physiology Physiology Physiology and PharmacologyPharmacology Pharmacology Pharmacology Pharmacology Physiol Pharmacol 23 (2019) 21-27 www.phypha.ir/ppj Abstract Introduction: Ursolic acid (UA) is a triterpenoid compound which widely found in the apple’s peel. It has wide health-promoting properties; as previous studies properly indicated to its abilities. In this scenario our attention has been paid to the application of UA as an anti-diabetic compound. Based on our recent studies in relating to SIRT1 protein/gene and UA, the aim of this research was to evaluate UA effects on the SIRT1 expression in diabetic rat’s pancreas. Methods: In this study we used 20 male diabetic wistar rats. To develop diabetic rats, they received 30mg/kg of streptozotocin for 2 days sequentially. Then, they classified to 2 groups, the ones received UA + corn oil twice daily for two weeks and others (the control group) just received corn oil. Results: Our findings obviously showed that UA enhanced SIRT1 (4±0.2 folds) proteins levels in pancreas (P&#60;0.001), in comparison with control rats. In addition, the findings showed that UA significantly decreased fasting blood glucose from 416.17±12 mg/dl to 149.75±11 mg/dl. Moreover, we found that UA increased β-cell numbers and islet Langerhans diameters (~2 folds). Conclusion: Our results provide valuable information not only into the mechanisms underlying β-cells protection but also into the regulation of SIRT1 as a main target to attenuate β-cells damage. Therefore, UA is a promising pharmacological therapeutic target for β-cell regeneration through enhancing of SIRT1 over-expression. iD</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>nuredin.bakhtiary@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>SIRT1</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ursolic acid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Diabetes.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Bakhtiari N, Hosseinkhani S, Soleimani M, Hemmati R, Noori-Zadeh A, Javan M, et al. Short-term ursolic acid promotes skeletal muscle rejuvenation through enhancing of SIRT1 expression and satellite cells proliferation. Biomed Pharmacother 2016; 78: 185-196.##Bakhtiari N, Hosseinkhani S, Tashakor A, Hemmati R. Ursolic acid ameliorates aging-metabolic phenotype through promoting of skeletal muscle rejuvenation. Med Hypotheses 2015a; 85: 1-6.##Bakhtiari N, Mirzaie S, Hemmati R, Moslemee-jalalvand E, Noori AR, Kazemi J. Mounting evidence validates Ursolic Acid directly activates SIRT1: a powerful STAC which mimic endogenous activator of SIRT1. Arch Biochem Biophys 2018; 650: 39-48.##Bakhtiari N, Soulemani M, Javan M, Hemmati R, Hosseinkhani S. Ursolic acid induces myoglobin expression and skeletal muscle remodeling in mice. Physiol Pharmacol 2015b; 18: 373-82.##Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic β cells. PLoS biol 2015; 13: e1002346.##Castro AJ, Frederico MJ, Cazarolli LH, Mendes CP, Bretanha LC, Schmidt ÉC, et al. The mechanism of action of ursolic acid as insulin secretagogue and insulinomimetic is mediated by cross-talk between calcium and kinases to regulate glucose balance. Biochim Biophys Acta 2015; 1850: 51-61.##de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 2010; 59: 1006-15.##Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, et al. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011; 335: 166-76.##Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, et al. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int Immunopharmacol 2009; 9: 113-9.##Kitada M, Koya D. SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J 2013; 37: 315-25.##Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013; 124: 153-64.##Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, et al. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 2011; 13: 627-38.##Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009; 58: 344-51.##Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Méneur C, et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2005; 2: 105-17.##van Loosdregt J, Brunen D, Fleskens V, Pals CE, Lam EW, Coffer PJ. Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PloS One 2011; 6: e19047.##Wang ZH, Hsu CC, Huang CN, Yin MC. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur J Pharmacol 2010; 628: 255-60.##Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29: 1363-74.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Interferon-alpha reduced inflammatory effects of filgrastim (G-CSF) in the liver of Syrian mice</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: granulocyte colony-stimulating factor (G-CSF) has been widely used for the treatment of chemotherapy-induced neutropenia. One of the major sideeffects of interferon-&#945; (IFN-&#945;) therapy is neutropenia. Previous studies have confirmed the beneficial effects of co-administration of G-CSF and IFN-&#945; on neutropenia in patients infected with hepatitis C. In this study for the first time, the effects of co-administration of type I IFNs and G-CSF on liver and liver enzymes investigated. Methods: forty-two mice (male, eight weeks) were randomly divided into six groups of seven: distilled water, G-CSF (200&#956;g/kg), IFN-&#945; (200&#956;g/kg), IFN-&#946; (200&#956;g/kg), IFN-&#945;+G-CSF and IFN-&#946;+G-CSF. After 28 days, blood was taken from the heart of each mouse and histological changes in the liver and liver enzymes including aspartate transaminase (AST) and alanine transaminase (ALT), as well as bilirubin, were measured. Results: Surprisingly, in most cases, the G-CSF and type one IFNs alone or simultaneously reduced the levels of AST and bilirubin. The levels of ALT induced by IFN-&#945;, the addition of G-CSF to IFN-&#945; reduced the level of this liver enzyme. G-CSF induced cell infiltrations into the liver tissue, addition of IFN-&#945; but not IFN-&#946; to G-CSF obviously reduced the cell infiltration into the liver. Conclusion: Since the changes in liver enzymes and bilirubin were not at harmful levels, and the administration of IFN-&#945; to G-CSF reduced the cell infiltrations into the liver, our results suggested that co-administration of type I IFNs and G-CSF had no harmful effects on liver histology and functions.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>28</FPAGE>
			<TPAGE>35</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/212018/03/17
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/12/26
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/282018/12/24
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/10/3
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Ensieh</Name>
				<MidName></MidName>
				<Family>Namjou</Family>
				<NameE>Ensieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Namjou</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>en_na981@stu.mail.um.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Roya</Name>
				<MidName></MidName>
				<Family>Lari</Family>
				<NameE>Roya</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Lari</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>rlari@um.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nasser</Name>
				<MidName></MidName>
				<Family>Mahdavi Shahri</Family>
				<NameE>Nasser</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mahdavi Shahri</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mahdavin@um.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Moghimi</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moghimi</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moghimi@um.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Inflammation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IFN-α</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IFN-β</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>G-CSF</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Liver enzymes.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Ameli M, Besharati S, Nemati K, Zamani F. Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran. Saudi Med J 2008; 29: 1611-5.##Benveniste EN, Qin H. Type I interferons as anti-inflammatory mediators. Sci STKE 2007 (416): pe70.##Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-94.##Crow MK. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther 2010; 12 Suppl 1: S5.##Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82-93.##Dkhil MA, Al-Quraishy S, Diab MM, Othman MS, Aref AM, Abdel Moneim AE. The potential protective role of Physalis peruviana L. fruit in cadmium-induced hepatotoxicity and nephrotoxicity. Food Chem Toxicol 2014; 74: 98-106.##Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, et al. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 2008; 112: 5193-201.##Fiuza C, Salcedo M, Clemente G, Tellado JM. Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease. Clin Diagn Lab Immunol 2002; 9: 433-9.##Francis GS, Grumser Y, Alteri E, Micaleff A, O'Brien F, Alsop J, et al. Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance. Drug Saf 2003; 26: 815-27.##Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006; 45: 13-9.##Ghezzi P, Saccardo B, Bianchi M. Induction of xanthine oxidase and heme oxygenase and depression of liver drug metabolism by interferon: a study with different recombinant interferons. J Interferon Res 1986; 6: 251-6.##Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005; 172: 367-79.##Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. A review on laboratory liver function tests. Pan Afr Med J 2009; 3: 17.##Huang SS, Huang PH, Wu TC, Chen JW, Lin SJ. Association of serum bilirubin with contrast-induced nephropathy and future cardiovascular events in patients undergoing coronary intervention. PLoS One 2012; 7: e42594.##Koskinas J, Zacharakis G, Sidiropoulos J, Elefsiniotis J, Savvas S, Kotsiou S, et al. Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: a preliminary report on treatment, safety and efficacy. J Med Virol 2009; 81: 848-52.##Li N, Zhang L, Li H, Fang B. Administration of granulocyte colony-stimulating factor ameliorates radiation-induced hepatic fibrosis in mice. Transplant Proc 2010; 42: 3833-9.##Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, et al. Reversibility of cirrhosis in chronic hepatitis B. Clin Gastroenterol Hepatol 2004; 2: 344-7.##Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol 1999; 31 Suppl 1: 9-16.##Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, et al. High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 713-8.##Palmer G, Mezin F, Juge-Aubry CE, Plater-Zyberk C, Gabay C, Guerne PA. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts. Ann Rheum Dis 2004; 63: 43-9.##Pascussi JM, Vilarem MJ. Inflammation and drug metabolism: NF-kappB and the CAR and PXR xeno-receptors. Med Sci (Paris) 2008; 24: 301-5.##Refaat B, El-Shemi AG, Ashshi AM. The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes 2015; 8: 265.##Renwick W, Pettengell R, Green M. Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience. BioDrugs 2009; 23: 175-86.##Sharvadze L, Gochitashvili N, Tophuria A, Bolokadze N, Tsertsvadze T. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C. Georgian Med News 2007, p. 52-5.##Shen H, Zhang M, Minuk GY, Gong Y. Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation. BMC Cell Biol 2002; 3: 9.##Sookoian S, Pirola CJ. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol 2015; 21: 711-25.##Stüve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996; 40: 853-63.##Tajuddin T, Ryan EJ, Norris S, Hegarty JE, O'Farrelly C. Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist. J Gastroenterol Hepatol 2010; 25: 1883-90.##Todriia TV, Kaplanskaia IB. Side effect of granulocytic colony-stimulating factor on the structure and function of mouse liver. Ter Arkh 2006; 78: 56-9.##Wei Q, Hill WD, Su Y, Huang S, Dong Z. Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am J Physiol Renal Physiol 2011; 301: F162-70.##Zhu H, Wang J, Jiang H, Ma Y, Pan S, Reddy S, et al. Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation. Exp Mol Med 2010; 42: 739-48.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Atorvastatin attenuates D-galactose-induced hepatorenal toxicity in mice: an experimental study with histopathological evaluations</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Atorvastatin (Ator) is a lipid lowering drug with potent antioxidant and anti-inflammatory properties. The present investigation was designed to study the effect of Ator on D-galactose (GAL)-induced hepatorenal toxicity in mice. Methods: In this study, 40 mice were divided into 4 groups: normal, GAL (500 mg/kg), Ator 0.1 (0.1mg/kg)+GAL and Ator 1 (1mg/kg)+GAL. Ator and GAL were administered orally for 6 weeks simultaneously. Then on day 43, blood samples were collected to determine blood urea nitrogen (BUN), serum creatinine (sCr), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. The kidneys and livers samples were used for histological examination. Results: Our results indicated that administration of GAL significantly increases sCr, BUN, ALT and AST. Co-administration of Ator 0.1 and 1mg/kg with GAL for 6 weeks (especially 1mg/kg) attenuated these changes. Histological changes in kidney such as infiltration of leukocyte, necrosis and oedema were observed in GAL group. Moreover, pyknosis, infiltration of inflammatory cell and fat deposit were observed in the livers of GAL-treated mice. Co-administration of Ator 0.1 and 1mg/kg with GAL for 6 weeks (especially 1mg/kg) could mitigate the histological lesions in kidneys and livers of GAL-administered animals. Conclusion: The results of this study suggested that Ator may have beneficial effects on hepatorenal toxicity induced by GAL.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>36</FPAGE>
			<TPAGE>43</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/212018/03/172018/08/22
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/5/31
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/282018/12/242019/02/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/11/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Zahra</Name>
				<MidName></MidName>
				<Family>Taghipour</Family>
				<NameE>Zahra</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Taghipour</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>dr.taghipour@rums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Elham</Name>
				<MidName></MidName>
				<Family>Kaviani</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kaviani</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ekaviani1394@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ayat</Name>
				<MidName></MidName>
				<Family>Kaeidi</Family>
				<NameE>Ayat</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kaeidi</FamilyE>
				<Organizations>
				<Organization>Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>a.kaeidi@rums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Shamsizadeh</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shamsizadeh</FamilyE>
				<Organizations>
				<Organization>Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ashamsi@rums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Jalal</Name>
				<MidName></MidName>
				<Family>Hassanshahi</Family>
				<NameE>Jalal</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hassanshahi</FamilyE>
				<Organizations>
				<Organization>Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hasanshahij@rums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Iman</Name>
				<MidName></MidName>
				<Family>Fatemi</Family>
				<NameE>Iman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fatemi</FamilyE>
				<Organizations>
				<Organization>Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>si_fatami@rums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hepatorenal toxicity</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>D-galactose</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Atorvastatin.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, et al. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. J Gastroenterol Hepatol 2012; 27: 1353-61.##Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong HJ, et al. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int 2015; 35: 2174-86.##Amin KA, Abd El-Twab TM. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. Int J Clin Exp Med 2009; 2: 254-65.##Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004; 57: 728-34.##Bedi O, Dhawan V, Sharma PL, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol 2016; 389: 695-712.##Ehsani V, Amirteimoury M, Taghipour Z, Shamsizadeh A, Bazmandegan G, Rahnama A, et al. Protective effect of hydroalcoholic extract of Pistacia vera against gentamicin-induced nephrotoxicity in rats. Ren Fail 2017; 39: 519-525.##El-Moselhy MA, El-Sheikh AA. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. Biomed Pharmacother 2014; 68: 101-10.##Fan SH, Zhang ZF, Zheng YL, Lu J, Wu DM, Shan Q, et al. Troxerutin protects the mouse kidney from d-galactose-caused injury through anti-inflammation and anti-oxidation. Int Immunopharmacol 2009; 9: 91-6.##Fatemi I, Heydari S, Kaeidi A, Shamsizadeh A, Hakimizadeh E, Khaluoi A, et al. Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice. Fundam Clin Pharmacol 2018a; 32: 392-399.##Fatemi I, Khaluoi A, Kaeidi A, Shamsizadeh A, Heydari S, Allahtavakoli MA. Protective effect of metformin on D-galactose-induced aging model in mice. Iran J Basic Med Sci 2018b; 21: 19-25.##Ghaznavi H, Fatemi I, Kalantari H, Hosseini Tabatabaei SMT, Mehrabani M, Gholamine B, et al. Ameliorative effects of gallic acid on gentamicin-induced nephrotoxicity in rats. J Asian Nat Prod Res 2017; 1-12.##Girona J, La Ville AE, Sola R, Plana N, Masana L. Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am J Cardiol 1999; 83: 846-51.##Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 2004; 110: 856-61.##He X, Yang J, Li L, Tan H, Wu Y, Ran P, et al. Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro. Mol Med Rep 2017; 15: 1963-1972.##Kalaz EB, Coban J, Aydin AF, Doğan-Ekici I, Doğru-Abbasoglu S, Oztezcan S, et al. Carnosine and taurine treatments decreased oxidative stress and tissue damage induced by D-galactose in rat liver. J Physiol Biochem 2014; 70: 15-25.##Kaviani E, Rahmani M, Kaeidi A, Shamsizadeh A, Allahtavakoli M, Mozafari N, et al. Protective effect of atorvastatin on d-galactose-induced aging model in mice. Behav Brain Res 2017; 334: 55-60.##Majsterek I, Gloc E, Blasiak J, Reiter RJ. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J Pineal Res 2005; 38: 254-63.##Mehrzadi S, Fatemi I, Malayeri AR, Khodadadi A, Mohammadi F, Mansouri E, et al. Ellagic acid mitigates sodium arsenite-induced renal and hepatic toxicity in male Wistar rats. Pharmacol Rep 2018; 70: 712-719.##Mehrzadi S, Kamrava SK, Dormanesh B, Motevalian M, Hosseinzadeh A, Hosseini Tabatabaei SM, et al. Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney. Can J Physiol Pharmacol 2016; 94: 265-71.##Pisani A, Uccello F, Cesaro A, Comi N, Mirenghi F, Serio V, et al. Effects of atorvastatin on ischemic acute renal failure in aging rats. G Ital Nefrol 2002; 19: 534-9.##Prajapati SK, Garabadu D, Krishnamurthy S. Coenzyme Q10 prevents mitochondrial dysfunction and facilitates pharmacological activity of atorvastatin in 6-OHDA induced dopaminergic toxicity in rats. Neurotox Res 2017; 31: 478-492.##Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005; 19: 117-25.##Wei H, Li L, Song Q, Ai H, Chu J, Li W. Behavioural study of the D-galactose induced aging model in C57BL/6J mice. Behav Brain Res 2005; 157: 245-51.##Xu Y, Wu T, Jin Y, Fu Z. Effects of age and jet lag on D-galactose induced aging process. Biogerontology 2009; 10: 153-61.##Xu Y, Zhang J, Liu J, Li S, Li C, Wang W, et al. Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation. Nat Prod Res 2015; 29: 1078-82.##Yue R, Zuo C, Zeng J, Su B, Tao Y, Huang S, et al. Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway. Ren Fail 2017; 39: 643-651.##Zhao J, Cheng Q, Ye P, Yang G, Liu S, Ao Q, et al. Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels. Exp Gerontol 2016; 74: 37-42.##Zhou S, Zhao P, Li Y, Deng T, Tian L, Li H. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism. Eur J Pharmacol 2014; 740: 9-14.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effects of renal ischemia-reperfusion on biochemical factors and histopathological alterations in the liver of male rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: One of the main reasons for acute renal failure is the renal ischemiareperfusion. It seems that renal ischemia-reperfusion-induced oxidative stress not only lead to alterations in renal function but also causes tissue alterations in distant organs such as the liver. The purposes of this study were to investigate the effects of renal ischemia-reperfusion on biochemical factors and histopathological changes in the liver of male rats. Methods: Forty male rats were randomly divided into 4 groups: control, the sham group (only laparotomy), right nephrectomy and ischemic-reperfusion (right nephrectomy + left ischemic- reperfusion). In the end, following anesthesia, blood and liver samples were taken for the measurement of biochemical factors (malondialdehyde (MDA), superoxide dismutase (SOD), aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine aminotransferase (ALT) levels) and histopathological changes. Results: The result of this study indicated that renal ischemia-reperfusion significantly decreased SOD and increased MDA, AST, ALP and ALT compared to sham-control group (P&#60;0.05). In addition, histopathological findings show that ischemia-reperfusion significantly increased apoptotic cells (P&#60;0.05) and causes the disorganized arrangement of the hepatic plate, severe hepatocellular cytoplasmic vacuolation and extensive nuclear pyknosis. Conclusion: Our findings suggest that renal ischemia-reperfusion-induced liver damage, accompanied by decreasing of antioxidant capacity and increasing of oxidative stress and apoptosis in the liver.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>44</FPAGE>
			<TPAGE>50</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/212018/03/172018/08/222018/09/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/6/25
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/282018/12/242019/02/182018/12/31
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/10/10
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Hadi</Name>
				<MidName></MidName>
				<Family>Yousefi</Family>
				<NameE>Hadi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yousefi</FamilyE>
				<Organizations>
				<Organization>Khoy University of Medical Sciences, Khoy, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>yousefi@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nasser</Name>
				<MidName></MidName>
				<Family>Ahmadiasl</Family>
				<NameE>Nasser</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahmadiasl</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ahmadyn@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ramin</Name>
				<MidName></MidName>
				<Family>Salimnejad</Family>
				<NameE>Ramin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salimnejad</FamilyE>
				<Organizations>
				<Organization>Research Laboratory for Embryology and Stem Cells, Department of Anatomical Sciences and Pathology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>r.salimnejad@arums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Elhameh</Name>
				<MidName></MidName>
				<Family>Bagheri</Family>
				<NameE>Elhameh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bagheri</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>bagheri@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Leila</Name>
				<MidName></MidName>
				<Family>Roshangar</Family>
				<NameE>Leila</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Roshangar</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>roshangar@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Alireza</Name>
				<MidName></MidName>
				<Family>Alihemmati</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alihemmati</FamilyE>
				<Organizations>
				<Organization>Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hemmati@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Renal ischemia-reperfusion</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oxidative Stress</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Liver</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Biochemical factors</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Histopathological alterations.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Alihemmati A, Yousefi H, Ahmadiasl N, Habibi P. Apoptosis and histopathology of the heart after renal ischemia-reperfusion in male rat running title: Ischemia-reperfusion injury. Brazilian Archives of Biology and Technology 2017; 60.##Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Annals of Clinical &#38; Laboratory Science 2006; 36: 326-332.##Asaga T, Ueki M, Chujo K, Taie S. Jte-607, an inflammatory cytokine synthesis inhibitor, attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats. Journal of bioscience and bioengineering 2008; 106: 22-26.##Basireddy M, Isbell TS, Teng X, Patel RP, Agarwal A. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. American Journal of Physiology-Renal Physiology 2006; 290: F779-F786.##Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney international 1993; 43: 1160-1178.##Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. The Journal of clinical investigation 2011; 121: 4210-4221.##Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease? Kidney international 2004; 66: 480-485.##Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nature medicine 2011; 17: 1391.##Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: Protective effects of erdosteine and n-acetylcysteine. Urological research 2006; 34: 41-46.##Eschwege P, Paradis V, Conti M, Holstege A, Richet F, Deteve J, et al. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. The Journal of urology 1999; 162: 553-557.##Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annual review of physiology 1995; 57: 311-332.##Hazrati A, Salimnejad R, Alipour M, Mirzaei Bavil F, Alihemmati A. Protective effect of ghrelin on testicular damages caused by chronic hypoxia in rats: A histopathological study. Andrologia 2018; 50: e12989.##Hussein A, Abd-Elkhabir A, Abozahra A, Baiomy A, Ashamallah SA, Sheashaa HA, et al. Pancreatic injury secondary to renal ischemia/reperfusion (i/r) injury: Possible role of oxidative stress. Physiological Research 2014; 63: 47.##Khastar H, Kadkhodaee M, reza Sadeghipour H, Seifi B, Hadjati J, Najafi A, et al. Liver oxidative stress after renal ischemia-reperfusion injury is leukocyte dependent in inbred mice. Iranian journal of basic medical sciences 2011a; 14: 534.##Khastar H, Kadkhodaee M, Seifi B, Hadjati J, Najafi A, Soleimani M. Liver oxidative stress after renal ischemia-reperfusion injury is leukocyte dependent in inbred mice. Iranian journal of basic medical sciences 2011b; 14: 534-539.##Kruger NJ. The bradford method for protein quantitation. The protein protocols handbook: Springer, 2002: 15-21.##Kumar R, Boon-Bee Goh G. Chronic hepatitis b and fatty liver: Issues in clinical management. Clin Res Hepatol Gastroenterol 2016.##Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, et al. Acute kidney injury leads to inflammation and functional changes in the brain. Journal of the American Society of Nephrology 2008; 19: 1360-1370.##Mizutani A, Okajima K, Uchiba M, Isobe H, Harada N, Mizutani S, et al. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 2003; 101: 3029-3036.##Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. American Journal of Physiology-Renal Physiology 2018.##Park SW, Chen SW, Kim M, Brown KM, Kolls JK, D D'Agati V, et al. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Laboratory Investigation 2011; 91: 63.##Salimnejad R, Soleimani Rad J, Mohammad Nejad D, Roshangar L. Effect of ghrelin on total antioxidant capacity, lipid peroxidation, sperm parameters and fertility in mice against oxidative damage caused by cyclophosphamide. Andrologia 2018; 50: e12883.##Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON. Changes in hepatic tnf-α levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. Journal of Surgical Research 2002; 107: 234-240.##Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nature Reviews Nephrology 2011; 7: 189.##Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Reactive oxygen species in biological systems: Springer, 2002: 657-675.##Sundari PN, Wilfred G, Ramakrishna B. Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat? Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1997; 1362: 169-176.##Sural S, Sharma R, Sharma RK, Gupta A, Sharma A, Gulati S. Acute renal failure associated with liver disease in india: Etiology and outcome. Renal failure 2000; 22: 623-634.##Yildirim A, Gumus M, Dalga S, Sahin YN, Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Annals of Clinical &#38; Laboratory Science 2003; 33: 459-464.##Yousefi H, Ahmadiasl N, Alihemmati A, Habibi P. Effect of renal ischemia-reperfusion on lung injury and inflammatory responses in male rat. Iranian journal of basic medical sciences 2014; 17: 802.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Protective effects of walnut extract against oxidative damage in acetic acid-induced experimental colitis rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Walnuts (Juglans regia), has been shown to exert anti-inflammatory and antioxidant effects. The present study was designed to evaluate the anti-inflammatory and antioxidant effects of walnut extract (WE) on an experimental model of ulcerative colitis caused by intracolonic administration of acetic acid in rats. Methods: A total number of 30 rats were used, randomly assigned to five groups of 6 rats each. Group I: colitis without treatment (colitis control), group II: normal animals (normal control), in groups III and IV colitis induced rats were treated with WE (10 and 20mg/kg) for 8 consecutive days, and group V were treated with sulfasalazine (SLS, 200mg/kg) as a standard drug. Several parameters, including macroscopic and histopathological scores and malondialdehyde (MDA), total sulfhydryl (SH) groups, colonic superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities were measured using standard assay procedures. Results: Results revealed that treatment with 10mg/kg WE for 8 days attenuated the macroscopic and histopathological colonic damage scores as well as colonic levels of MDA, while increased the levels of total SH, SOD and GPx compared with colitis untreated group. The 20mg/kg dose had no protective effects. Conclusion: These findings suggest that protective effect of WE in the experimental model of colitis could be through an antioxidant mechanism.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>51</FPAGE>
			<TPAGE>58</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/212018/03/172018/08/222018/09/162018/09/21
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/6/30
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/282018/12/242019/02/182018/12/312019/01/20
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/10/30
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Zakieh</Name>
				<MidName></MidName>
				<Family>Keshavarzi</Family>
				<NameE>Zakieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Keshavarzi</FamilyE>
				<Organizations>
				<Organization>Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Zakieh_Keshavarzi@nkums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Nurmohammadi</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nurmohammadi</FamilyE>
				<Organizations>
				<Organization>College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Fatemeh.Nur@nkums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Saba</Name>
				<MidName></MidName>
				<Family>Majlesi</Family>
				<NameE>Saba</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Majlesi</FamilyE>
				<Organizations>
				<Organization>College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>S_Majlesi@nkums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Maghool</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Maghool</FamilyE>
				<Organizations>
				<Organization>Poursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>f.maghool@girc.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Ulcerative colitis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Walnut extract</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Antioxidant.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Amaral JS, Casal S, Pereira JA, Seabra RM, Oliveira BP: Determination of sterol and fatty acid compositions, oxidative stability, and nutritional value of six walnut (juglans regia l.) cultivars grown in portugal. Journal of Agricultural and Food Chemistry 2003;51:7698-7702.##Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM: Walnut polyphenolics inhibit in vitro human plasma and ldl oxidation. The Journal of nutrition 2001;131:2837-2842.##Atmani D, Chaher N, Atmani D, Berboucha M, Debbache N, Boudaoud H: Flavonoids in human health: From structure to biological activity. Current Nutrition &#38; Food Science 2009;5:225-237.##Azza H, Guemei AA, Hagar HH, El-Medany JH, Baraka AM: Comparative study between effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on acetic acid-induced ulcerative colitis in rats. 2011.##Baradaran A, Rabiei Z, Rafieian M: A review study on medicinal plants affecting amnesia through cholinergic system. Journal of HerbMed Pharmacology. 2012;1.##Choi CH, Jung SA, Lee BI, Lee KM, Kim JS, Han DS: Diagnostic guideline of ulcerative colitis. The Korean journal of gastroenterology= Taehan Sohwagi Hakhoe chi 2009;53:145-160.##Daneshmand A, Rahimian R, Mohammadi H, Ejtemaee-Mehr S, Tavangar SM, Kelishomi RB, Dehpour AR: Protective effects of lithium on acetic acid-induced colitis in rats. Digestive diseases and sciences 2009;54:1901-1907.##Del Maestro R: An approach to free radicals in medicine and biology. Acta Physiologica Scandinavica Supplementum 1980;492:153-168.##Del Rio D, Stewart AJ, Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, metabolism and cardiovascular diseases 2005;15:316-328.##Drew JE, Arthur JR, Farquharson AJ, Russell WR, Morrice PC, Duthie GG: Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon. Biochemical pharmacology 2005;70:888-893.##Fukuda T, Ito H, Yoshida T: Antioxidative polyphenols from walnuts (juglans regia l.). Phytochemistry 2003;63:795-801.##Fukuda T, Ito H, Yoshida T: Effect of the walnut polyphenol fraction on oxidative stress in type 2 diabetes mice. Biofactors 2004;21:251-253.##Grisham MB: Oxidants and free radicals in inflammatory bowel disease. The Lancet 1994;344:859-861.##Grisham MB, Gaginella TS, von Ritter C, Tamai H, Robert MB, Granger DN: Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 1990;14:531-542.##Hilsden RJ, Scott CM, Verhoef MJ: Complementary medicine use by patients with inflammatory bowel disease. The American journal of gastroenterology 1998;93:697-701.##Hosseinzadeh H, Sadeghnia HR: Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci. 2005 Aug 22;8(3):394-9.##Iwamoto M, Imaizumi K, Sato M, Hirooka Y, Sakai K, Takeshita A, Kono M: Original communications-serum lipid profiles in japanese women and men during consumption of walnuts. European journal of clinical nutrition 2002;56:629-637.##Kazemi S, Asgary S, Moshtaghian J, Rafieian M, Adelnia A, Shamsi F: Liver-protective effects of hydroalcoholic extract of allium hirtifolium boiss. In rats with alloxan-induced diabetes mellitus. ARYA atherosclerosis. 2010;6(1):11.##Kruidenier La, Verspaget H: Oxidative stress as a pathogenic factor in inflammatory bowel disease—radicals or ridiculous? Alimentary pharmacology &#38; therapeutics 2002;16:1997-2015.##Kuralay F, Yildiz C, Ozutemiz O, Islekel H, Caliskan S, Bingol B, Ozkal S: Effects of trimetazidine on acetic acid-induced colitis in female swiss rats. Journal of Toxicology and Environmental Health Part A 2003;66:169-179.##Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton D: Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: An in vitro study. Alimentary pharmacology &#38; therapeutics 2002;16:197-205.##Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digestive diseases and sciences 1996;41:2078-2086.##Maguire L, O'sullivan S, Galvin K, O'connor T, O'brien N: Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. International journal of food sciences and nutrition 2004;55:171-178.##Majid S, Khanduja KL, Gandhi RK, Kapur S, Sharma RR: Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochemical pharmacology 1991;42:1441-1445.##Millar A, Rampton D, Chander C, Claxson A, Blades S, Coumbe A, Panetta J, Morris C, Blake D: Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996;39:407-415.##Mokhtari M: Effect of walnut (juglans regia) extract on serum LH, FSH and testosterone levels in adult male rat. Journal of Ardabil University of Medical Sciences 2012;12:157-165.##Moody G, Eaden J, Bhakta P, Sher K, Mayberry J: The role of complementary medicine in european and asian patients with inflammatory bowel disease. Public health 1998;112:269-271.##Naini BV, Cortina G: A histopathologic scoring system as a tool for standardized reporting of chronic (ileo) colitis and independent risk assessment for inflammatory bowel disease. Human pathology 2012;43:2187-2196.##Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry 1979;95:351-358.##Rafieian-Kopaei M, Asgary S, Adelnia A, Setorki M, Khazaei M, Kazemi S, Shamsi F: The effects of cornelian cherry on atherosclerosis and atherogenic factors in hypercholesterolemic rabbits. Journal of Medicinal Plants Research. 2011 Jul 4;5(13):2670-6.##Reiter RJ, Manchester L, Tan D-x: Melatonin in walnuts: Influence on levels of melatonin and total antioxidant capacity of blood. Nutrition 2005;21:920-924.##Rutgeerts P, Van Deventer S, Schreiber S: The expanding role of biological agents in the treatment of inflammatory bowel disease–focus on selective adhesion molecule inhibition. Alimentary pharmacology &#38; therapeutics 2003;17:1435-1450.##Seguí J, Gil F, Gironella M, Alvarez M, Gimeno M, Coronel P, Closa D, Piqué JM, Panés J: Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis. Inflammatory bowel diseases 2005;11:872-882.##Şengül N, Işık S, Aslım B, Uçar G, Demirbağ AE: The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis. Digestive diseases and sciences 2011;56:707-714.##Simmonds NJ, Allen RE, Stevens TR, Niall R, Van Someren M, Blake DR, Rampton DS: Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103:186-196.##Soszyński M, Bartosz G: Decrease in accessible thiols as an index of oxidative damage to membrane proteins. Free Radical Biology and Medicine 1997;23:463-469.##Taji F, Pourgheysari B, Raisi S, Rafieian-Kopaei M: Comparison of antitumour activities of heated and raw garlic extracts on fibrosarcoma in mice. Journal of Babol University of Medical Sciences. 2012;14(6):77-83.##Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, Oteiza PI: Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radical Biology and Medicine 2003;34:84-92.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Transient modulation of hydroxyzine, an antihistamine and anxiolytic agent, on the cardiac autonomic activity in healthy subjects</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Despite the experimental evidence available on the modulating effects of the H1 receptors on the autonomic function, limited research has been done the effects of such receptors through measuring the heart rate variability (HRV) indexes in human. The present study aims to assess the effect of the acute administration of different doses of hydroxyzine on the time and frequency domain of HRV indexes. Methods: Four experiment sessions were held for the fifteen healthy participants. In each session, after the 5-minute baseline electrocardiogram (ECG) recording, one of the four interventions (the intake of a 5, 10 or 20mg hydroxyzine or a placebo) was performed and then the 5-minute ECG recordings were repeated at 30, 60, 90, 120, 180 and 240 minutes after the oral administration. Results: The statistical analysis has shown that at minute 30, hydroxyzine has an inhibitory effect on the sympathetic index low frequency (LFnu), which is eliminated at minute 180. Moreover, from minute 60, hydroxyzine increases vagal HRV indexes, which are then eliminated at minute 240. Conclusion: The findings of the present study showed that histamines, mediated by H1 receptors, have a modulating effect on the cardiac autonomic; however, this modulating effect is then neutralized or eliminated in a short time probably by other cardiac regulatory mechanisms.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>59</FPAGE>
			<TPAGE>69</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/08/92018/10/112019/01/212018/03/172018/08/222018/09/162018/09/212018/12/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/9/25
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2019/01/212019/02/152019/02/282018/12/242019/02/182018/12/312019/01/202019/02/22
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/12/3
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Fateme</Name>
				<MidName></MidName>
				<Family>Rezaeyanzade</Family>
				<NameE>Fateme</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaeyanzade</FamilyE>
				<Organizations>
				<Organization>School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>f.rezaeyanzade@mazums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nematollah</Name>
				<MidName></MidName>
				<Family>Ahangar</Family>
				<NameE>Nematollah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahangar</FamilyE>
				<Organizations>
				<Organization>Pharmaceutical Sciences Research Center and Department of Toxicology and Pharmacology, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>n.ahangar@mazums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Abbas</Name>
				<MidName></MidName>
				<Family>Alipour</Family>
				<NameE>Abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alipour</FamilyE>
				<Organizations>
				<Organization>Department of Community Medicine, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>alipour.abbas@mazums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Ghaemian</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaemian</FamilyE>
				<Organizations>
				<Organization>Mazandaran Heart Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>a.ghaemian@mazums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Esmaeil</Name>
				<MidName></MidName>
				<Family>Akbari</Family>
				<NameE>Esmaeil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbari</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>akbari_esmaeil@mazums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Histamine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Heart rate variability</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hydroxyzine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Autonomic nervous system.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Agelink MW, Malessa R, Baumann B, Majewski T, Akila F, Zeit T, et al. Standardized tests of heart rate variability: Normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res 2001; 11: 99-108.##Akbari E, Forotan SA. The effect of dicyclomine hydrochloride, an anticholinergic agent, on heart rate variability and squatting test in healthy volunteers. Journal of Mazandaran University of Medical Sciences 2009; 19: 10-17.##Akbari E, Zare AH, Alipour A. The effect of oxybutynin on cardiac autonomic modulation in healthy subjects. Clin Auton Res 2014; 24: 167-74.##Alcalay M, Izraeli S, Wallach-Kapon R, Tochner Z, Benjamini Y, Akselrod S. Paradoxical pharmacodynamic effect of atropine on parasympathetic control: A study by spectral analysis of heart rate fluctuations. Clin Pharmacol Ther 1992; 52: 518-27.##Appel ML, Berger RD, Saul JP, Smith JM, Cohen RJ. Beat to beat variability in cardiovascular variables: Noise or music? J Am Coll Cardiol 1989; 14: 1139-48.##Bealer SL. Central neuronal histamine contributes to cardiovascular regulation. News Physiol Sci 1999; 14: 100-105.##Casadei B, Pipilis A, Sessa F, Conway J, Sleight P. Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction. Circulation 1993; 88: 353-7.##Christian EP, Undem BJ, Weinreich D. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol 1989; 409: 297-312.##Christian EP, Weinreich D. Presynaptic histamine h1 and h3 receptors modulate sympathetic ganglionic synaptic transmission in the guinea-pig. J Physiol 1992; 457: 407-30.##Conen S, Theunissen EL, Vermeeren A, van Ruitenbeek P, Stiers P, Mehta MA, et al. The role of p-glycoprotein in cns antihistamine effects. Psychopharmacology (Berl) 2013; 229: 9-19.##del Cuvillo A, Mullol J, Bartra J, Davila I, Jauregui I, Montoro J, et al. Comparative pharmacology of the h1 antihistamines. J Investig Allergol Clin Immunol 2006; 16 Suppl 1: 3-12.##Hattori T, Watanabe S, Kano M, Kanazawa M, Fukudo S. Differential responding of autonomic function to histamine h(1) antagonism in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 1284-91, e335.##Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42: 45-83.##Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International :::::union::::: of pharmacology. Xiii. Classification of histamine receptors. Pharmacol Rev 1997; 49: 253-78.##Holgate ST, Canonica GW, Simons FE, Taglialatela M, Tharp M, Timmerman H, et al. Consensus group on new-generation antihistamines (conga): Present status and recommendations. Clin Exp Allergy 2003; 33: 1305-24.##Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H. Organization of histaminergic fibers in the rat brain. J Comp Neurol 1988; 273: 283-300.##Jutel M, Blaser K, Akdis CA. Histamine in chronic allergic responses. J Investig Allergol Clin Immunol 2005; 15: 1-8.##Kavanagh JJ, Grant GD, Anoopkumar-Dukie S. Low dosage promethazine and loratadine negatively affect neuromotor function. Clin Neurophysiol 2012; 123: 780-6.##Kemp AH, Fraguas R, Brunoni AR, Bittencourt MS, Nunes MA, Dantas EM, et al. Differential associations of specific selective serotonin reuptake inhibitors with resting-state heart rate and heart rate variability: Implications for health and well-being. Psychosom Med 2016; 78: 810-8.##Lader M, Scotto JC. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology (Berl) 1998; 139: 402-6.##Lee CH, Lee JH, Son JW, Kim U, Park JS, Lee J, et al. Normative values of short-term heart rate variability parameters in koreans and their clinical value for the prediction of mortality. Heart Lung Circ 2018; 27: 576-587.##Matheny CJ, Lamb MW, Brouwer KR, Pollack GM. Pharmacokinetic and pharmacodynamic implications of p-glycoprotein modulation. Pharmacotherapy 2001; 21: 778-96.##Nishiyama T. Effects of premedication on heart rate variability at induction of anaesthesia: Comparison between midazolam and hydroxyzine. Turk J Anaesthesiol Reanim 2018; 46: 229-232.##Paton DM, Webster DR. Clinical pharmacokinetics of h1-receptor antagonists (the antihistamines). Clin Pharmacokinet 1985; 10: 477-97.##Poole SL, Lewis DI, Deuchars SA. Histamine depolarizes neurons in the dorsal vagal complex. Neurosci Lett 2008; 432: 19-24.##Powers MJ, Peterson BA, Hardwick JC. Regulation of parasympathetic neurons by mast cells and histamine in the guinea pig heart. Auton Neurosci 2001; 87: 37-45.##Schreihofer AM, Stornetta RL, Guyenet PG. Regulation of sympathetic tone and arterial pressure by rostral ventrolateral medulla after depletion of c1 cells in rat. J Physiol 2000; 529 Pt 1: 221-36.##Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71: 1-51.##Simons FE. Advances in h1-antihistamines. N Engl J Med 2004; 351: 2203-17.##Simons FE, Simons KJ. H1 antihistamines: Current status and future directions. World Allergy Organ J 2008; 1: 145-55.##Snowman AM, Snyder SH. Cetirizine: Actions on neurotransmitter receptors. J Allergy Clin Immunol 1990; 86: 1025-8.##Snow RW, Weinreich D. Presynaptic and postsynaptic effects of histamine and histamine agonists in the superior cervical ganglion of the rat. Neuropharmacology 1987; 26: 743-52.##Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. Am Heart J 1994; 127: 1376-81.##Task Force. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task force of the european society of cardiology and the north american society of pacing and electrophysiology. Circulation 1996; 93: 1043-65.##Vybiral T, Bryg RJ, Maddens ME, Bhasin SS, Cronin S, Boden WE, et al. Effects of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol 1990; 65: 604-8.##Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984; 295: 13-25.##Whyment AD, Blanks AM, Lee K, Renaud LP, Spanswick D. Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of h1 receptors. J Neurophysiol 2006; 95: 2492-500.##Yeh TL, Yang YK, Chiu NT, Yao WJ, Yeh SJ, Wu JS, et al. Correlation between striatal dopamine d2/d3 receptor binding and cardiovascular activity in healthy subjects. Am J Hypertens 2006; 19: 964-9.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
